Naloxone Hydrochloride/Pentazocine Hydrochloride

盐酸纳洛酮/盐酸喷他佐辛

Report date: 2023/03/09 15:23:33

Base Information

Drug NameNaloxone Hydrochloride/Pentazocine Hydrochloride
Drug Alias Name盐酸喷他佐辛/盐酸纳洛酮Pentazocine/Naloxone盐酸喷他佐辛盐酸纳洛酮Naloxone/Pentazocine盐酸纳洛酮盐酸喷他佐辛 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors agonistsOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsBipolar DisorderAcute Pain
Global Approved IndicationsAcute Pain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1982/12/16
Country/TerritoryUnited States
CombinationsYes Naloxone HydrochloridePentazocine Hydrochloride
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Aventis U.S. LlcStanley Medical Research Institute
Active IndicationsN/A
Inactive IndicationsBipolar DisorderAcute Pain

Other Information

ATC CodeN/A
Related LinksN/A